University Training Program in Biomolecular and Tissue Engineering
University Training Program in Biomolecular and Tissue Engineering
批准号:
9069933
负责人:
Charles A. Gersbach
金额:
$37.06万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-07-01 至 2017-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The current proposal seeks renewal of the NIGMS biotechnology training program in Biomolecular and Tissue Engineering (BTE) at Duke University. The objective of the biotechnology training program in BTE is to provide classroom, laboratory, and research predoctoral training in the design, manipulation, and quantitative characterization of biomolecules, cells and tissues. The training program in BTE involves 31 training faculty with 17 faculty from the Pratt School of Engineering (Biomedical Engineering, Civil & Environmental Engineering, Mechanical Engineering & Materials Science) and 14 faculty from non-engineering fields. Of the non-engineering BTE faculty, 5 are in the Trinity College of Arts & Sciences (Chemistry, Computer Science), and 9 in the Basic Medical Science (Cell Biology, Radiation Oncology, Surgery, Bioinformatics, Medicine, Ophthalmology, and Radiology) and Clinical Departments of the Duke University Medical Center (Obstetrics & Gynecology, Medicine, Pathology, Radiation Oncology, Radiology, Surgery). Over the 17 years of NIGMS support, a total of 68 students have received predoctoral traineeships in BTE: 42 trainees have received their doctorates, 18 are still in training, and 7 have left the program. The
disciplinary breakdown of trainees is 47 in BME, 10 in ME&MS, 7 in Chemistry, and 1 each in Biochemical Engineering, Electrical Engineering, Cell Biology, Zoology, and Bioinformatics & Genome Technology. BTE predoctoral trainees are required to (1) perform research that is interdisciplinary in nature and is central to the development of medical biotechnology, (2) have at least two BTE faculty on their doctoral dissertation committee, (3) take one of three approved laboratory-based engineering courses in modern biotechnology, (4) take four engineering electives that provide breadth in BTE [trainees entering the program from non-engineering disciplines select two engineering electives], (5) take two advanced courses in the biomedical sciences relevant to BTE, (6) take two semesters of the interdisciplinary "BioE" seminar series for credit, (7) participate in a three-month industrial biotechnology internship, (8) present in th annual BTE poster session, and (9) undergo training in responsible conduct in research. The BTE training grant currently supports 9 fellows for two years commencing in either the first or second year of graduate study. We request that this level of support be maintained.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
University Training Program in Biomolecular and Tissue Engineering
-
批准号:10652660
-
项目类别:
-
资助金额:$53.05万
-
财政年份:2022
-
负责人:Charles A. Gersbach
-
依托单位:
Epigenome Editing Technologies for Treating Diverse Disease
-
批准号:9810824
-
项目类别:
-
资助金额:$40.04万
-
财政年份:2019
-
负责人:Charles A. Gersbach
-
依托单位:
Epigenome Editing Technologies for Treating Diverse Disease
-
批准号:10214461
-
项目类别:
-
资助金额:$39.87万
-
财政年份:2019
-
负责人:Charles A. Gersbach
-
依托单位:
Epigenome Editing Technologies for Treating Diverse Disease
-
批准号:9973203
-
项目类别:
-
资助金额:$38.51万
-
财政年份:2019
-
负责人:Charles A. Gersbach
-
依托单位:
Epigenome Editing Technologies for Treating Diverse Disease
-
批准号:10438803
-
项目类别:
-
资助金额:$39.85万
-
财政年份:2019
-
负责人:Charles A. Gersbach
-
依托单位:
CRISPR/Cas9-Based Gene Editing for the Correction of Duchenne Muscular Dystrophy
-
批准号:9888311
-
项目类别:
-
资助金额:$33.94万
-
财政年份:2016
-
负责人:Charles A. Gersbach
-
依托单位:
In Vivo Epigenome Editing with CRISPR-Based Histone Acetyltransferase Transgenic Mice
-
批准号:9132500
-
项目类别:
-
资助金额:$19.88万
-
财政年份:2016
-
负责人:Charles A. Gersbach
-
依托单位:
In Vivo Epigenome Editing with CRISPR-Based Histone Acetyltransferase Transgenic
-
批准号:9895699
-
项目类别:
-
资助金额:$38.06万
-
财政年份:2016
-
负责人:Charles A. Gersbach
-
依托单位:
CRISPR/Cas9-Based Gene Editing for the Correction of Duchenne Muscular Dystrophy
-
批准号:9237199
-
项目类别:
-
资助金额:$33.94万
-
财政年份:2016
-
负责人:Charles A. Gersbach
-
依托单位:
Scaffold-Mediated Gene Delivery for Engineering of Osteochondral Tissues
-
批准号:9069429
-
项目类别:
-
资助金额:$19.96万
-
财政年份:2015
-
负责人:Charles A. Gersbach
-
依托单位:
Scaffold-Mediated Gene Delivery for Engineering of Osteochondral Tissues
-
批准号:8815847
-
项目类别:
-
资助金额:$16.67万
-
财政年份:2015
-
负责人:Charles A. Gersbach
-
依托单位:
Genome Editing of Stem Cells for Analysis of Osteoarthritis Causal Variants
-
批准号:8663739
-
项目类别:
-
资助金额:$17.27万
-
财政年份:2014
-
负责人:Charles A. Gersbach
-
依托单位:
Spatially Controlled Gene Delivery of Morphogenetic Factors from Woven Scaffolds
-
批准号:8100077
-
项目类别:
-
资助金额:$7.61万
-
财政年份:2011
-
负责人:Charles A. Gersbach
-
依托单位:
Spatially Controlled Gene Delivery of Morphogenetic Factors from Woven Scaffolds
-
批准号:8452615
-
项目类别:
-
资助金额:$7.22万
-
财政年份:2011
-
负责人:Charles A. Gersbach
-
依托单位:
Engineering Morphogenetic Factors for Enhanced Genetic Reprogramming
-
批准号:8146777
-
项目类别:
-
资助金额:$235.5万
-
财政年份:2011
-
负责人:Charles A. Gersbach
-
依托单位:
Spatially Controlled Gene Delivery of Morphogenetic Factors from Woven Scaffolds
-
批准号:8249080
-
项目类别:
-
资助金额:$7.61万
-
财政年份:2011
-
负责人:Charles A. Gersbach
-
依托单位:
Regulating Sensitivity to Cancer Therapy with Engineered Transcription Factors
-
批准号:7220428
-
项目类别:
-
资助金额:$4.68万
-
财政年份:2007
-
负责人:Charles A. Gersbach
-
依托单位:
Regulating Sensitivity to Cancer Therapy with Engineered Transcription Factors
-
批准号:7590466
-
项目类别:
-
资助金额:$1.67万
-
财政年份:2007
-
负责人:Charles A. Gersbach
-
依托单位:
Regulating Sensitivity to Cancer Therapy with Engineered Transcription Factors
-
批准号:7429645
-
项目类别:
-
资助金额:$4.96万
-
财政年份:2007
-
负责人:Charles A. Gersbach
-
依托单位:
University Training Program in Biomolecular and Tissue Engineering
-
批准号:8895340
-
项目类别:
-
资助金额:$41.05万
-
财政年份:1994
-
负责人:Charles A. Gersbach
-
依托单位:
海外基金